[Registration of new clopidogrel preparations--an attack on patent protection?].
Bruhn
C
C
D000077144:Clopidogrel; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence* / Q000639:trends; D005858:Germany; D006801:Humans; D010330:Patents as Topic / Q000941:ethics / Q000331:legislation & jurisprudence*; D010975:Platelet Aggregation Inhibitors / Q000737:chemistry / Q000493:pharmacokinetics / Q000592:standards*; D013810:Therapeutic Equivalency; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000592:standards
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine